One Step Influenza A Test is a rapid qualitative assay that detects influenza type A (including the subtype H1N1) nucleoprotein antigen extracted from the nasal swab specimen. The device is used to aid in the diagnosis of influenza type A infection.
For in vitro diagnostic use only. For professional use only.
Influenza A SUMMARY
Influenza (commonly known as flu) is a highly contagious, acute viral infection of the respiratory tract. It is a communicable disease that is easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the autumn and winter months. There are three types of influenza viruses: A, B, and C. Only influenza A viruses are further classified by subtype on the basis of the two main surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). Influenza A subtypes and B viruses are further classified by strains.
Humans can be infected with influenza types A, B, and C viruses. Subtypes of influenza A that are currently circulating among people worldwide include H1N1, H1N2, and H3N2 viruses. Influenza B viruses can cause morbidity and mortality among humans, but in general are associated with less severe epidemics than influenza A viruses. Although influenza type B viruses can cause human epidemics, they have not caused pandemics. Influenza type C viruses cause mild illness in humans and do not cause epidemics or pandemics.
Influenza A PRINCIPLE
One Step Influenza A Test is a rapid immunochromatographic test for the visual detection of influenza type A antigen (nucleoprotein) extracted from the nasal swab specimen. The test adopts double antibody sandwich method.
When the extracted specimen is added into the test device, the specimen is absorbed into the device by capillary action, mixes with antibody-dye conjugate, and flows across the membrane pre-coated with influenza type A monoclonal antibody.
When the influenza type A antigen levels are at or above the target cutoff (the detection limit of the test), type A antigen in the specimen binds to the specific antibody-dye conjugate and are captured by influenza type A monoclonal antibody immobilized in the relative site of test region T of the device. This produces a colored test band in the test region. When the influenza type A antigen levels are zero or below the target cut off, there is not a visible colored band in the test region of the device. This indicates a negative result for influenza type A.
SARS-CoV-2 Rapid Antigen Test kit Colloidal Gold Method Medical Simple Rapid Convenient Sensitivity : 98.4% Specificity : 98.1% Test Time : 10-15min
Shelf lifespan: 18 months Sensitivity: 92.23% Specificity: 95.34% Other rapid test kits could be optional, such as fertility, sexual transmitted diseases test, cardiac marker test, tumor marker test, drugs of abuse test, infectious disease test, biosecurity and miscellaneous test
Rapid Influenza A + B Test Card Intended Use Influenza A+B Test is an in vitro immunochromatographic assay for the qualitative detection of influenza type A and type B nucleoprotein antigens in nasopharyngeal swab, nasal swab and nasal aspirate samples. The identification is based on the monoclonal antibodies specific for the nucleoprotein of Influenza virus A. It is intended to aid in the rapid diagnosis of influenza infection. Negative results should be confirmed by other methods, such as cell culture. Contents of Kit Flu A + B Test Card 20 ea Sample Extraction Buffer 1 ea Extraction Tube 20 ea Nozzle With Filter 21 ea Sterilized Swab 20 ea Tube Stand 1 ea Instructions For Use 1 ea Storage And Stability Store the Influenza A+B Rapid Test at room temperature or refrigerated (2-30ípC). Do not freeze. All reagents are stable until the expiration dates marked on their outer packaging and buffer vial. Pre Cautions 1. For in vitro diagnostic use only. 2. Do not use after the expiration date. 3. The test device should remain in the sealed pouch until use. 4. If the Influenza A+B Rapid Test kit was kept refrigerated, let all the reagents warm up to room temperature (15ípC -30ípC) before proceeding with the test. 5. Wear gloves when handing the samples, avoid touching the reagent membrane with your fingers. 6. Discard gloves, swabs, test tubes, and test devices in accordance with the local regulation. 7. Visibly bloody samples should not be used for the testing. 25 tests/kit, 40 kits/carton
Supplier: Rapid detection kit, ribonucleic acid detection reagent, medical syringes, medical mask, medical ventilator, medical glove, medical isolation gown, surgical gown level 3+4, protective gown (overall ), oximeter, other medical products
Canine Influenza Virus Ag Test is a sandwich lateral flow immunochromatographic assay for the qualitative detection of canine Influenza virus (CIV Ag) in dog's secretions. Assay Time: 5 -10 min Sample: Secretions Canine Influenza Virus Ag Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window. The testing window has an invisible T (test) zone and C (control) zone. When a sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough Influenza antigen in the sample, a visible T band will appear. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of Canine Influenza antigen in the sample.
RAPID TEST IgG/IgM - EMERGENCY RESPONSE KIT FROM THE UNITED STATES! The COVID-19 Rapid Test for Screening, Diagnosis, and Monitoring is a lateral flow immunoassay, a way to qualitatively assess the presence of IgG and IgM antibodies specific for SARS-CoV-2 from a person sample Product advantages COUNTRY OF ORIGIN The United States EARLY DISCOVERY Individual test avoids cross-infection WHOLE SPECTRUM The cover early, mid and late phase of the disease FAST RESULTS 10 minutes HIGH ACCURACY 98,43% EFFICIENCY Two types of tests on one cassette with quick result SAFETY Individual test avoids cross-infection
VivaDiag Pro SARS-CoV-2 Ag Rapid Test 396.000 pcs in stock in Prague. This is repeated every week. On order can be unlimited pieces. 25pcs in box PRICE DEPEND ON QUANTITY IN ALL CASE WE CAN MAKE BEST PRICE FOR YOU. CE 1434 REF VCD16-01-011 Manual IFU ENG, DE, PORTUGAL, FRANCE, CZECH, GREECE, ITALIAN Photos, documents and video can be sent. Please contact me.
The novel Antigen Rapid Test swab is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in Nasopharyngeal swab and Oropharyngeal swab using the rapid method with a reading result in 10-15 minutes.
Antigen Rapid tests. Nasal swab, 1T/kit. SingClean - 1,2 euro/unit. . Sejoy - 1.35 euro/unit Boson - 1,8 euro/unit
